A Wealth of Experience

We have collaborated with our clients on projects to research vaccines for various diseases.  Our experience includes: 

  • Cholera
  • Dengue fever
  • Hepatitis
  • Human papillomavirus (HPV)
  • Influenza (including H1N1)
  • Malaria
  • Measles
  • Meningococcal, conjugate (including MCV4)
  • Meningococcal, polysaccharide (MPSV4)
  • Mumps
  • Pertussis
  • Pneumococcal conjugate (PCV)
  • Pneumococcal polysaccharide (PPSV)
  • Respiratory syncytial virus (RSV)
  • Rotavirus
  • Rubella
  • Staphylococcus aureus
  • Tetanus, diphtheria (Td)
  • Tetanus, diphtheria, and pertussis (Tdap)
  • Typhoid
  • Typhoid fever
  • Varicella
  • Zoster

Types of Projects

We have implemented studies to help our clients develop strategies in the vaccine market and to develop and gain market access for vaccines to prevent various diseases.  Recent project types have included:

Our Experts

Christine Poulos
Senior Economist and Vice President, Health Preference Assessment
Josephine Mauskopf
Vice President, Health Economics
William L Herring
Senior Director, Health Economics
Keith Davis
Head, Health Economics
Bradley Layton
Director, Epidemiology
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Bintu Sherif
Director, Biostatistics
Katherine Hicks
Senior Director, Health Economics
Kelly Hollis
Vice President, Surveys and Observational Studies
Jonathan Graham
Senior Director, Health Economics
Jin Yang
Associate Director, Market Access and Outcomes Strategy
Anita Brogan
Vice President, Decision Analytic Modeling, Health Economics
Sandra Talbird
Executive Director, Health Economics
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy

Selected Recent Vaccines Publications